AQR Capital Management LLC Boosts Stock Holdings in Maximus, Inc. (NYSE:MMS)

AQR Capital Management LLC boosted its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 189.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 423,298 shares of the health services provider's stock after buying an additional 276,859 shares during the period. AQR Capital Management LLC owned approximately 0.74% of Maximus worth $31,599,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in MMS. Vanguard Group Inc. increased its holdings in Maximus by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock worth $488,829,000 after purchasing an additional 205,564 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Maximus by 14.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock worth $105,001,000 after buying an additional 177,075 shares in the last quarter. Van Berkom & Associates Inc. raised its position in Maximus by 8.5% in the 4th quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock valued at $93,792,000 after buying an additional 98,264 shares during the last quarter. Fuller & Thaler Asset Management Inc. lifted its stake in Maximus by 7.4% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider's stock valued at $92,188,000 after acquiring an additional 84,835 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Maximus by 7.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock worth $74,700,000 after acquiring an additional 71,598 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

Maximus Stock Performance

Shares of NYSE MMS traded up $0.75 during mid-day trading on Wednesday, reaching $67.22. 372,600 shares of the company's stock were exchanged, compared to its average volume of 559,164. The firm has a 50-day moving average price of $67.64 and a two-hundred day moving average price of $73.36. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The firm has a market capitalization of $3.80 billion, a price-to-earnings ratio of 14.46 and a beta of 0.61. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.79%. The ex-dividend date is Thursday, May 15th. Maximus's dividend payout ratio is presently 25.81%.

Insider Transactions at Maximus

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the company's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. This represents a 85.23 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.